REGN logo

REGN Free Cash Flow

Annual FCF:

$3.54B-$128.70M(-3.51%)
December 31, 2024

Summary

  • As of today, REGN annual free cash flow is $3.54 billion, with the most recent change of -$128.70 million (-3.51%) on December 31, 2024.
  • During the last 3 years, REGN annual free cash flow has fallen by -$2.99 billion (-45.80%).
  • REGN annual free cash flow is now -45.80% below its all-time high of $6.53 billion, reached on December 31, 2021.

Performance

REGN Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNcash flow metrics

Quarterly FCF:

$737.60M-$36.00M(-4.65%)
June 30, 2025

Summary

  • As of today, REGN quarterly free cash flow is $737.60 million, with the most recent change of -$36.00 million (-4.65%) on June 30, 2025.
  • Over the past year, REGN quarterly free cash flow has increased by +$594.50 million (+415.44%).
  • REGN quarterly free cash flow is now -77.51% below its all-time high of $3.28 billion, reached on September 30, 2021.

Performance

REGN Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNcash flow metrics

TTM FCF:

$3.56B+$594.50M(+20.07%)
June 30, 2025

Summary

  • As of today, REGN TTM free cash flow is $3.56 billion, with the most recent change of +$594.50 million (+20.07%) on June 30, 2025.
  • Over the past year, REGN TTM free cash flow has increased by +$371.90 million (+11.68%).
  • REGN TTM free cash flow is now -55.19% below its all-time high of $7.94 billion, reached on March 31, 2022.

Performance

REGN TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

REGN Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-3.5%+415.4%+11.7%
3Y3 Years-45.8%+79.5%-54.8%
5Y5 Years+76.9%-9.3%+124.8%

REGN Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-45.8%+4.2%-49.7%+267.5%-18.4%+40.8%
5Y5-Year-45.8%+76.9%-77.5%+267.5%-55.2%+124.8%
All-TimeAll-Time-45.8%+1879.2%-77.5%+267.5%-55.2%+1260.0%

REGN Free Cash Flow History

DateAnnualQuarterlyTTM
Jun 2025
-
$737.60M(-4.7%)
$3.56B(+20.1%)
Mar 2025
-
$773.60M(-22.3%)
$2.96B(-16.3%)
Dec 2024
$3.54B(-3.5%)
$995.80M(-5.1%)
$3.54B(+6.6%)
Sep 2024
-
$1.05B(+633.3%)
$3.32B(+4.2%)
Jun 2024
-
$143.10M(-89.4%)
$3.18B(-19.0%)
Mar 2024
-
$1.35B(+74.0%)
$3.93B(+7.1%)
Dec 2023
$3.67B(+7.9%)
$776.20M(-15.1%)
$3.67B(-15.9%)
Sep 2023
-
$914.40M(+2.9%)
$4.36B(+45.1%)
Jun 2023
-
$888.50M(-18.4%)
$3.00B(+18.9%)
Mar 2023
-
$1.09B(-25.8%)
$2.53B(-25.6%)
Dec 2022
$3.40B(-48.0%)
$1.47B(+433.3%)
$3.40B(-18.1%)
Sep 2022
-
-$440.40M(-207.2%)
$4.15B(-47.3%)
Jun 2022
-
$410.80M(-79.0%)
$7.87B(-0.8%)
Mar 2022
-
$1.96B(-11.6%)
$7.94B(+21.5%)
Dec 2021
$6.53B(+225.9%)
$2.22B(-32.4%)
$6.53B(+21.3%)
Sep 2021
-
$3.28B(+586.0%)
$5.38B(+217.8%)
Jun 2021
-
$478.20M(-13.6%)
$1.69B(-16.5%)
Mar 2021
-
$553.20M(-48.3%)
$2.03B(+1.3%)
Dec 2020
$2.00B(+0.2%)
$1.07B(+362.5%)
$2.00B(+26.6%)
Sep 2020
-
-$407.50M(-150.1%)
$1.58B(-34.8%)
Jun 2020
-
$813.50M(+54.1%)
$2.43B(+42.2%)
Mar 2020
-
$527.90M(-18.6%)
$1.71B(-14.7%)
Dec 2019
$2.00B(+10.4%)
$648.40M(+48.9%)
$2.00B(+0.3%)
Sep 2019
-
$435.60M(+364.9%)
$2.00B(+4.7%)
Jun 2019
-
$93.70M(-88.6%)
$1.91B(-9.0%)
Mar 2019
-
$822.70M(+27.9%)
$2.10B(+15.6%)
Dec 2018
$1.81B(+75.2%)
$643.37M(+85.6%)
$1.81B(+11.3%)
Sep 2018
-
$346.71M(+22.7%)
$1.63B(-0.5%)
Jun 2018
-
$282.55M(-47.6%)
$1.64B(+29.0%)
Mar 2018
-
$539.37M(+17.4%)
$1.27B(+22.6%)
Dec 2017
$1.03B(+7.6%)
$459.29M(+29.3%)
$1.03B(+28.9%)
Sep 2017
-
$355.18M(+515.8%)
$802.62M(-18.1%)
Jun 2017
-
-$85.42M(-128.0%)
$979.92M(-26.1%)
Mar 2017
-
$305.44M(+34.3%)
$1.33B(+37.9%)
Dec 2016
$961.46M(+47.3%)
$227.42M(-57.3%)
$961.46M(+14.7%)
Sep 2016
-
$532.47M(+104.3%)
$838.08M(-20.4%)
Jun 2016
-
$260.66M(+541.0%)
$1.05B(+32.3%)
Mar 2016
-
-$59.10M(-156.8%)
$795.41M(+21.8%)
Dec 2015
$652.85M(+59.2%)
$104.04M(-86.1%)
$652.85M(+3.7%)
Sep 2015
-
$746.75M(>+9900.0%)
$629.54M(+1983.6%)
Jun 2015
-
$3.71M(+101.8%)
-$33.42M(-115.2%)
Mar 2015
-
-$201.66M(-349.8%)
$219.78M(-46.4%)
Dec 2014
$410.15M(-4.0%)
$80.74M(-3.6%)
$410.15M(-23.7%)
Sep 2014
-
$83.79M(-67.4%)
$537.22M(+4.5%)
Jun 2014
-
$256.92M(+2374.6%)
$514.19M(+46.5%)
Mar 2014
-
-$11.29M(-105.4%)
$350.99M(-17.9%)
Dec 2013
$427.32M(+444.8%)
$207.81M(+242.0%)
$427.32M(+43.6%)
Sep 2013
-
$60.76M(-35.2%)
$297.54M(+32.7%)
Jun 2013
-
$93.71M(+44.1%)
$224.15M(+472.0%)
Mar 2013
-
$65.05M(-16.6%)
$39.19M(+131.6%)
Dec 2012
-$123.95M(+37.7%)
$78.02M(+717.8%)
-$123.95M(+53.0%)
Sep 2012
-
-$12.63M(+86.2%)
-$263.58M(+14.0%)
Jun 2012
-
-$91.25M(+7.0%)
-$306.58M(-16.0%)
Mar 2012
-
-$98.10M(-59.2%)
-$264.25M(-32.9%)
Dec 2011
-$198.90M(-5846.2%)
-$61.61M(-10.7%)
-$198.90M(+5.8%)
Sep 2011
-
-$55.63M(-13.7%)
-$211.25M(-1138.7%)
Jun 2011
-
-$48.91M(-49.4%)
-$17.05M(-409.6%)
Mar 2011
-
-$32.75M(+55.7%)
-$3.35M(-0.1%)
Dec 2010
-$3.35M(+98.0%)
-$73.96M(-153.4%)
-$3.35M(-276.4%)
Sep 2010
-
$138.57M(+493.6%)
$1.90M(+101.1%)
Jun 2010
-
-$35.21M(-7.5%)
-$168.82M(-2.3%)
Mar 2010
-
-$32.74M(+52.4%)
-$164.99M(+2.7%)
Dec 2009
-$169.55M(-36.8%)
-$68.72M(-113.7%)
-$169.55M(-11.2%)
Sep 2009
-
-$32.15M(-2.5%)
-$152.41M(+10.9%)
Jun 2009
-
-$31.38M(+15.9%)
-$171.13M(-22.0%)
Mar 2009
-
-$37.30M(+27.7%)
-$140.30M(-13.2%)
Dec 2008
-$123.94M
-$51.58M(-1.4%)
-$123.94M(-284.0%)
DateAnnualQuarterlyTTM
Sep 2008
-
-$50.87M(-9234.7%)
-$32.28M(-1106.7%)
Jun 2008
-
-$545.00K(+97.4%)
$3.21M(+302.5%)
Mar 2008
-
-$20.94M(-152.2%)
-$1.58M(-117.7%)
Dec 2007
$8.93M(-56.0%)
$40.09M(+360.4%)
$8.93M(-57.4%)
Sep 2007
-
-$15.39M(-188.6%)
$20.93M(+0.3%)
Jun 2007
-
-$5.33M(+48.9%)
$20.88M(+301.7%)
Mar 2007
-
-$10.44M(-120.0%)
$5.20M(-74.4%)
Dec 2006
$20.26M(+157.5%)
$52.09M(+437.2%)
$20.26M(+138.9%)
Sep 2006
-
-$15.45M(+26.5%)
-$52.03M(+2.4%)
Jun 2006
-
-$21.02M(-553.7%)
-$53.30M(+14.6%)
Mar 2006
-
$4.63M(+122.9%)
-$62.40M(-77.0%)
Dec 2005
-$35.26M(-52.8%)
-$20.20M(-20.8%)
-$35.26M(-23.3%)
Sep 2005
-
-$16.71M(+44.5%)
-$28.59M(-60.8%)
Jun 2005
-
-$30.12M(-194.8%)
-$17.77M(-162.9%)
Mar 2005
-
$31.77M(+334.9%)
$28.26M(+222.4%)
Dec 2004
-$23.08M(+35.5%)
-$13.53M(-129.3%)
-$23.08M(+41.2%)
Sep 2004
-
-$5.90M(-137.1%)
-$39.27M(-256.8%)
Jun 2004
-
$15.91M(+181.3%)
$25.05M(+168.6%)
Mar 2004
-
-$19.57M(+34.1%)
-$36.55M(-2.1%)
Dec 2003
-$35.79M(+75.3%)
-$29.71M(-150.9%)
-$35.79M(+31.5%)
Sep 2003
-
$58.42M(+227.9%)
-$52.27M(+63.4%)
Jun 2003
-
-$45.69M(-142.9%)
-$142.87M(-6.9%)
Mar 2003
-
-$18.81M(+59.3%)
-$133.65M(+7.8%)
Dec 2002
-$144.89M(-121.1%)
-$46.20M(-43.6%)
-$144.89M(-21.8%)
Sep 2002
-
-$32.17M(+11.8%)
-$118.95M(-7.7%)
Jun 2002
-
-$36.47M(-21.3%)
-$110.44M(-29.1%)
Mar 2002
-
-$30.05M(-48.4%)
-$85.56M(-30.5%)
Dec 2001
-$65.54M(-90.5%)
-$20.25M(+14.4%)
-$65.54M(-30.5%)
Sep 2001
-
-$23.66M(-104.1%)
-$50.22M(-57.9%)
Jun 2001
-
-$11.59M(-15.4%)
-$31.81M(-21.9%)
Mar 2001
-
-$10.04M(-103.4%)
-$26.09M(+24.2%)
Dec 2000
-$34.41M(-76.3%)
-$4.93M(+5.9%)
-$34.41M(-47.6%)
Sep 2000
-
-$5.25M(+10.6%)
-$23.31M(+13.3%)
Jun 2000
-
-$5.87M(+68.0%)
-$26.89M(+5.5%)
Mar 2000
-
-$18.36M(-398.0%)
-$28.45M(-45.8%)
Dec 1999
-$19.52M(-47.3%)
$6.16M(+169.8%)
-$19.52M(+39.1%)
Sep 1999
-
-$8.83M(-18.9%)
-$32.05M(-57.8%)
Jun 1999
-
-$7.43M(+21.2%)
-$20.31M(-15.5%)
Mar 1999
-
-$9.42M(-47.9%)
-$17.59M(-32.8%)
Dec 1998
-$13.25M(-61.1%)
-$6.37M(-319.2%)
-$13.25M(-202.5%)
Sep 1998
-
$2.91M(+161.7%)
-$4.38M(+53.3%)
Jun 1998
-
-$4.71M(+7.3%)
-$9.39M(-8.1%)
Mar 1998
-
-$5.08M(-303.2%)
-$8.68M(-5.9%)
Dec 1997
-$8.22M(+71.5%)
$2.50M(+219.0%)
-$8.20M(+28.1%)
Sep 1997
-
-$2.10M(+47.5%)
-$11.40M(+32.1%)
Jun 1997
-
-$4.00M(+13.0%)
-$16.80M(+21.5%)
Mar 1997
-
-$4.60M(-557.1%)
-$21.40M(+26.0%)
Dec 1996
-$28.90M(-254.3%)
-$700.00K(+90.7%)
-$28.90M(-0.3%)
Sep 1996
-
-$7.50M(+12.8%)
-$28.80M(+12.7%)
Jun 1996
-
-$8.60M(+28.9%)
-$33.00M(-22.7%)
Mar 1996
-
-$12.10M(-1916.7%)
-$26.90M(-25.1%)
Dec 1995
-$8.16M(+49.8%)
-$600.00K(+94.9%)
-$21.50M(+32.4%)
Sep 1995
-
-$11.70M(-368.0%)
-$31.80M(-19.1%)
Jun 1995
-
-$2.50M(+62.7%)
-$26.70M(-36.2%)
Mar 1995
-
-$6.70M(+38.5%)
-$19.60M(+28.5%)
Dec 1994
-$16.25M(+60.5%)
-$10.90M(-65.2%)
-$27.40M(+18.5%)
Sep 1994
-
-$6.60M(-243.5%)
-$33.60M(+1.8%)
Jun 1994
-
$4.60M(+131.7%)
-$34.20M(+27.7%)
Mar 1994
-
-$14.50M(+15.2%)
-$47.30M(-17.4%)
Dec 1993
-$41.13M(-104.0%)
-$17.10M(-137.5%)
-$40.30M(-294.7%)
Sep 1993
-
-$7.20M(+15.3%)
$20.70M(+177.5%)
Jun 1993
-
-$8.50M(-13.3%)
-$26.70M(-15.6%)
Mar 1993
-
-$7.50M(-117.1%)
-$23.10M(-19.7%)
Dec 1992
-$20.16M(-123.5%)
$43.90M(+180.4%)
-$19.30M(+69.5%)
Sep 1992
-
-$54.60M(-1014.3%)
-$63.20M(-634.9%)
Jun 1992
-
-$4.90M(-32.4%)
-$8.60M(-132.4%)
Mar 1992
-
-$3.70M
-$3.70M
Dec 1991
-$9.02M
-
-

FAQ

  • What is Regeneron Pharmaceuticals, Inc. annual free cash flow?
  • What is the all-time high annual free cash flow for Regeneron Pharmaceuticals, Inc.?
  • What is Regeneron Pharmaceuticals, Inc. annual free cash flow year-on-year change?
  • What is Regeneron Pharmaceuticals, Inc. quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for Regeneron Pharmaceuticals, Inc.?
  • What is Regeneron Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?
  • What is Regeneron Pharmaceuticals, Inc. TTM free cash flow?
  • What is the all-time high TTM free cash flow for Regeneron Pharmaceuticals, Inc.?
  • What is Regeneron Pharmaceuticals, Inc. TTM free cash flow year-on-year change?

What is Regeneron Pharmaceuticals, Inc. annual free cash flow?

The current annual free cash flow of REGN is $3.54B

What is the all-time high annual free cash flow for Regeneron Pharmaceuticals, Inc.?

Regeneron Pharmaceuticals, Inc. all-time high annual free cash flow is $6.53B

What is Regeneron Pharmaceuticals, Inc. annual free cash flow year-on-year change?

Over the past year, REGN annual free cash flow has changed by -$128.70M (-3.51%)

What is Regeneron Pharmaceuticals, Inc. quarterly free cash flow?

The current quarterly free cash flow of REGN is $737.60M

What is the all-time high quarterly free cash flow for Regeneron Pharmaceuticals, Inc.?

Regeneron Pharmaceuticals, Inc. all-time high quarterly free cash flow is $3.28B

What is Regeneron Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?

Over the past year, REGN quarterly free cash flow has changed by +$594.50M (+415.44%)

What is Regeneron Pharmaceuticals, Inc. TTM free cash flow?

The current TTM free cash flow of REGN is $3.56B

What is the all-time high TTM free cash flow for Regeneron Pharmaceuticals, Inc.?

Regeneron Pharmaceuticals, Inc. all-time high TTM free cash flow is $7.94B

What is Regeneron Pharmaceuticals, Inc. TTM free cash flow year-on-year change?

Over the past year, REGN TTM free cash flow has changed by +$371.90M (+11.68%)
On this page